Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Jan 11 2021

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 11, 2021, titled "Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India".

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases